Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Wang, Yongsheng"'
Autor:
Bi Z; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250017, China., Wang X; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China., Qiu P; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250017, China., Chen P; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250017, China., Wang Y; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250017, China.
Publikováno v:
Cancer biology & medicine [Cancer Biol Med] 2023 Mar 02; Vol. 20 (2).
Autor:
Bi Z; School of Medicine & Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, Shandong, PR China.; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, PR China., Liu J; Laboratory, Qingdao Municipal Hospital, Qingdao, Shandong, PR China., Chen P; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, PR China., Song X; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, PR China., Wang Y; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, PR China.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2019 Aug; Vol. 15 (23), pp. 2669-2671.
Autor:
Bi Z; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Liu J; Laboratory, Qingdao Municipal Hospital, Qingdao, Shandong, People's Republic of China., Chen P; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Liu Y; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Zhao T; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Wang C; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Zhang Z; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Sun X; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Qiu P; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Cong B; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Song X; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China., Wang Y; Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Ji Yan Road 440, Jinan, Shandong Province, People's Republic of China. wangysh2008@aliyun.com.
Publikováno v:
Breast cancer (Tokyo, Japan) [Breast Cancer] 2019 May; Vol. 26 (3), pp. 373-377. Date of Electronic Publication: 2019 Jan 21.
Autor:
Qiu P; Breast Cancer Center, Shandong Cancer Hospital and Institute, Jinan, 250117, China., Zhao R; Department of Medicine, Shandong Cancer Hospital and Institute, Jinan, 250117, China., Cong B; Breast Cancer Center, Shandong Cancer Hospital and Institute, Jinan, 250117, China., Yang G; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Jinan, 250117, China., Liu Y; Breast Cancer Center, Shandong Cancer Hospital and Institute, Jinan, 250117, China., Chen P; Breast Cancer Center, Shandong Cancer Hospital and Institute, Jinan, 250117, China., Sun X; Breast Cancer Center, Shandong Cancer Hospital and Institute, Jinan, 250117, China., Wang C; Breast Cancer Center, Shandong Cancer Hospital and Institute, Jinan, 250117, China., Wang Y; Breast Cancer Center, Shandong Cancer Hospital and Institute, Jinan, 250117, China.
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2016 Jan; Vol. 38 (1), pp. 42-7.
Autor:
BI Zhao, WANG Yongsheng
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 6, Pp 560-565 (2023)
In the era of sentinel lymph node biopsy (SLNB), the axillary management concept that 1-2 positive sentinel lymph node (SLN) could safely omit axillary lymph node dissection (ALND) are gradually being accepted by more and more patients. The omission
Externí odkaz:
https://doaj.org/article/1068d41414b74019881134e8da656a30
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 6, Pp 574-580 (2023)
Background and purpose: With the increasing sensitivity of axillary imaging and ultrasound guided biopsy, some clinically axillary negative patients were upstaged to axillary positive (cN1) and received axillary lymph node dissection (ALND). This stu
Externí odkaz:
https://doaj.org/article/1ab54c80b8db44e6ae317b8fef9fa327
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 4, Pp 361-367 (2023)
Background and purpose: Multiple guidelines and consensus have confirmed the feasibility of sentinel lymph node biopsy (SLNB) after neoadjuvant therapy (NAT) in clinical nodal positive (cN+) patients converting to negative after NAT. There are few st
Externí odkaz:
https://doaj.org/article/c58128ad9b58447e98668c611ead7929
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 2, Pp 174-180 (2023)
In the era of effective systemic therapy and precise radiotherapy, neoadjuvant treatment (NAT) for breast cancer can de-escalate breast cancer treatment to conserve breast and spare axillary lymph node dissection (ALND). At present, high axillary nod
Externí odkaz:
https://doaj.org/article/3d8fd5a8f4d641c78e4275832525ab7b
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 2, Pp 142-151 (2023)
Background and purpose: Internal mammary lymph node irradiation (IMNI) improves survival in patients with internal mammary lymph node (IMLN) high-risk metastatic breast cancer. The purpose of this study was to study the advantages of internal mammary
Externí odkaz:
https://doaj.org/article/11307c3b7dee429a8ec403b724dda3e9
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 2, Pp 126-133 (2023)
Background and purpose: Both domestic and foreign guidelines recommend the use of radionuclide as sentinel lymph node (SLN) biopsy (SLNB) tracer, however this technique has not been popularized in China for a variety of reasons. Mitoxantrone hydrochl
Externí odkaz:
https://doaj.org/article/6f62e7e664e449e5957caa1ad34290e0